atai and Beckley Psytech plan to meet with the U.S. Food and Drug Administration (FDA) and other regulatory agencies to finalize the Phase 3 trial design.
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
The company has been awarded a contract for the supply of essential pharmaceutical formulations to government health institutions across Rajasthan
Viatel bioresorbable polymers are increasingly used in dental and orthopedic implants
TEVIMBRA is a uniquely designed anti-PD-1 monoclonal antibody developed by BeiGene (now BeOne Medicines)
The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold
Globally, BRUKINSA is approved in more than 70 countries
Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with Spinal Muscular Atrophy (SMA)
This strategic move positions Sudeep Pharma to seamlessly integrate high-end premix capabilities with its mineral portfolio
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
Subscribe To Our Newsletter & Stay Updated
